U.S. Food and Drug Administration
Dr. Liu is currently a clinical pharmacology reviewer at FDA, Office of Clinical Pharmacology/Office of Translational Sciences/CDER. Tao obtained his PhD in pharmaceutical sciences (focused on pharmacometrics) from University of Maryland Baltimore in 2017. Tao also obtained a Bachelor’s degree in Mathematics (2009) from Beijing Jiaotong University in China and worked as a biostatistician at Clinical Pharmacology Research Center, Peking Union Medical College Hospital from 2008 to 2012.
S22.1- Establishing Exposure/Response Relationships During CF Drug Development
Friday, September 27, 2024
2:30 PM – 4:30 PM ET